Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/17/2013

Company Name Symbol %Change
GLOBAL GEOPH GGS
7.79%
STAAR SURGIC STAA
6.23%
KAPSTONE PAP KS
6.14%
HORNBECK OFF HOS
5.99%
ANIKA THERAP ANIK
5.55%

Earnings Preview: Nash Finch

by Zacks Equity Research

July 18, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Nash Finch Company (NAFC - Analyst Report) is scheduled to report its second quarter 2012 financial results before the opening bell on Thursday, July 19, 2012.

The Zacks Consensus Estimate for second quarter earnings is pegged at 59 cents a share on revenues of $1,081.0 million.

The Zacks Consensus Estimate projects earnings for fiscal 2012 to be $2.72 per share on revenues of $4,786 million.

First Quarter Recap

Nash Finch Company’s first-quarter 2012 earnings (excluding one-time items) of 47 cents per share missed the Zacks Consensus Estimate of 55 cents by 14.5%. Additionally, it plunged 33.8% from prior-year quarter’s earnings of 71 cents per share. The ongoing macro-economic headwinds and increasing competition negatively affected the earnings.

Total sales in first quarter 2012 were $1.06 billion, down 3.7% from $1.10 billion in the prior-year quarter.

For further details please read: Poor 1Q for Nash Finch


Agreement of Estimate Revisions

Over the past 30 days, no movement was noticed in the three estimates either for the second quarter or for the full year.

The last revision in estimates took place in April, after the company announced its first quarter results.

Recently, on July 17, 2012, the company declared a regular quarterly cash dividend of 18 cents per share of common stock payable on September 7, 2012 to shareholders of record as on August 24, 2012.

Magnitude of Estimate Revisions

Given the limited estimate revisions, the consensus estimate for the second quarter of fiscal 2012 has remained static over the last 7 as well as 30 days at 59 cents. The consensus estimate for fiscal 2012 has also remained static at $2.72 over the last 7 as well 30 days.

Earnings Surprise History

With respect to earnings surprises, Nash Finch has topped the Zacks Consensus Estimate in three of the preceding four quarters. Over the last four quarters, its earnings surprise ranged from a negative 14.55% to a positive 18.29%, with the average earnings surprise being a negative 7.85%.

Recommendation

Though Nash Finch has been performing below expectation since the past few quarters, we prefer to remain on the sidelines due to the company’s long-term prospects. The company continues with its acquisition activities and it recently bought a number of supermarkets.

Currently, we have a long-term Neutral recommendation on Nash Finch, which carries a Zacks #3 Rank (short term Hold rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.